SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-012336
Filing Date
2021-09-09
Accepted
2021-09-09 06:41:21
Documents
66
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imrx-20210630x10q.htm   iXBRL 10-Q 2351224
2 EX-3.1 imrx-20210630xex3d1.htm EX-3.1 61070
3 EX-3.2 imrx-20210630xex3d2.htm EX-3.2 326060
4 EX-31.1 imrx-20210630xex31d1.htm EX-31.1 14688
5 EX-31.2 imrx-20210630xex31d2.htm EX-31.2 15955
6 EX-32.1 imrx-20210630xex32d1.htm EX-32.1 9356
7 EX-32.2 imrx-20210630xex32d2.htm EX-32.2 9978
  Complete submission text file 0001558370-21-012336.txt   6980027

Data Files

Seq Description Document Type Size
8 EX-101.SCH imrx-20210630.xsd EX-101.SCH 36740
9 EX-101.CAL imrx-20210630_cal.xml EX-101.CAL 38512
10 EX-101.DEF imrx-20210630_def.xml EX-101.DEF 169734
11 EX-101.LAB imrx-20210630_lab.xml EX-101.LAB 341525
12 EX-101.PRE imrx-20210630_pre.xml EX-101.PRE 301936
13 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20210630x10q_htm.xml XML 785955
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40675 | Film No.: 211243468
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences